Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01052415 · ClinicalTrials.gov registry record · NA
POL and Access Intervention to Reduce HIV Stigma Among Service Providers in China
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 5,400
- Enrollment target
NCT01052415: Completed NA study, sponsored by University of California, Los Angeles.
NCT01052415 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 5,400 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (285% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01052415, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,400 participants
- Enrollment target
Study Summary
In this project, UCLA's Center for Community Health (CCH) will develop an efficacious intervention trial integrating both individual and structural components to reduce HIV- related stigma among service providers in China and therefore benefit people living with HIV/AIDS (PLWHA). The purpose of this study is to develop a feasible, practical and low cost intervention strategy that will prevent and/or reduce the negative effects of HIV-related stigma among health service providers in China. This project will be conducted in two provinces and proceed in two phases. In Phase 1, confidential focus groups will take place with small samples of service providers and hospital administrators to finalize the intervention activities, and the investigators will also test and finalize the Audio Computer-Assisted Self-Interview (ACASI) assessment measures and implementation procedures with the same group of service providers. During Phase 1 a small sample of patients will anonymously test the paper-pencil baseline survey. Equal number of samples will be selected from two counties of each province. The findings from Phase 1 will be used to develop intervention, and revise assessment for Phase 2.
Interventions
- BEHAVIORAL Cognitive behavioral sessions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,400 participants |
| Start Date | 2007-09 |
| Est. Completion | 2011-08 |
| Phase | NA |
What the finished NCT01052415 record still lists
NCT01052415 is an interventional study that assigns participants to a tested intervention. Its 5,400 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (285% higher).
The record links to 0 conditions, and to 1 intervention - of which Cognitive behavioral sessions is the first listed.
NCT01052415 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01052415 about?
NCT01052415 is a clinical study titled "POL and Access Intervention to Reduce HIV Stigma Among Service Providers in China". In this project, UCLA's Center for Community Health (CCH) will develop an efficacious intervention trial integrating both individual and structural components to reduce HIV- related stigma among service providers in China and therefore benefit people living with HIV/AIDS (PLWHA). The purpose of thi...
What is the current status of trial NCT01052415?
This trial is currently completed. It is a NA study. The enrollment target is 5,400 participants. The study started on 2007-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01052415?
The interventions under investigation include: Cognitive behavioral sessions (BEHAVIORAL).
Who is sponsoring clinical trial NCT01052415?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01052415's enrollment target sits among peer trials
5,400 24th of 2000 higher than 1,977 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
- NCT05836987 · 5,350 participants · Phase 3
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia